Residency · Residency · Chronic Pain Management

Pain Taxonomy and Classification Systems

Overview

A coherent classification system for pain is essential for clinical communication, research standardization, treatment selection, and outcomes tracking. The evolution from purely biomedical models to the biopsychosocial framework has transformed how pain medicine conceptualizes and categorizes chronic pain. The 2019 ICD-11 classification of chronic pain represents a landmark advance in coding chronic pain as a disease entity in its own right.

IASP Definitions: Foundational Terminology

The International Association for the Study of Pain (IASP) provides the standardized definitions that underpin all pain taxonomy. The 2020 revised definition of pain reads: "An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage." This revision was accompanied by six explanatory notes emphasizing that pain is always a personal experience influenced by biological, psychological, and social factors; that pain and nociception are different phenomena; that a person's report of pain should be respected; and that the inability to communicate does not negate the possibility of pain.

Several other IASP definitions are foundational. Nociception refers to the neural process of encoding noxious stimuli and does not equal pain. Allodynia is pain due to a stimulus that does not normally provoke pain. Hyperalgesia is increased pain from a stimulus that normally provokes pain. Hyperpathia is an abnormally painful reaction to a stimulus, especially a repetitive one, with an increased threshold. Dysesthesia is an unpleasant abnormal sensation, whether spontaneous or evoked, while paresthesia is an abnormal sensation that is not necessarily unpleasant. Central sensitization is defined as increased responsiveness of nociceptive neurons in the CNS to their normal or subthreshold afferent input.

Mechanistic Pain Classification

Nociceptive Pain

Nociceptive pain arises from activation of nociceptors by actual or threatened damage to non-neural tissue, with an intact somatosensory nervous system. Somatic nociceptive pain is well-localized, aching, and throbbing -- examples include osteoarthritis, inflammatory arthritis, mechanical low back pain, and postoperative pain. Visceral nociceptive pain is poorly localized, deep, cramping, and colicky, often accompanied by referred pain patterns and autonomic features such as nausea and sweating; examples include pancreatitis, renal colic, and bowel obstruction. Because the somatosensory nervous system is intact, the neurological examination is normal. Nociceptive pain is typically responsive to NSAIDs, acetaminophen, and opioids.

Neuropathic Pain

Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Peripheral neuropathic pain includes conditions like postherpetic neuralgia, diabetic polyneuropathy, trigeminal neuralgia, post-traumatic neuropathy, and chemotherapy-induced neuropathy. Central neuropathic pain includes post-stroke pain, spinal cord injury pain, and multiple sclerosis pain. Clinically, neuropathic pain has a burning, shooting, or electric shock-like quality and is associated with numbness, tingling, allodynia, and hyperalgesia in a neuroanatomically plausible distribution.

The Finnerup grading system (2016) classifies neuropathic pain confidence into three levels. Possible neuropathic pain requires a neuroanatomically plausible pain distribution plus a history of relevant lesion or disease. Probable adds confirmatory clinical signs such as sensory loss or allodynia within the expected distribution. Definite requires a confirmatory diagnostic test such as nerve conduction studies, imaging, or biopsy. First-line treatments include gabapentinoids, SNRIs, and TCAs; second-line options are tramadol and topical agents; third-line includes strong opioids and botulinum toxin A.

Nociplastic Pain

Nociplastic pain is a relatively new IASP term (2017) describing pain arising from altered nociception despite no clear evidence of tissue damage activating peripheral nociceptors or disease or lesion of the somatosensory system. It represents the "third mechanism" -- neither purely nociceptive nor neuropathic. Examples include fibromyalgia, chronic widespread pain, irritable bowel syndrome, chronic primary headache, chronic pelvic pain syndromes, and non-specific chronic low back pain.

The pathophysiology involves central sensitization, impaired descending modulation, altered cortical processing, and neuroinflammation without an identifiable structural lesion. Clinically, patients present with widespread pain, fatigue, sleep disturbance, cognitive dysfunction, and multisensory hypersensitivity to light, sound, and odor, along with impaired conditioned pain modulation. Treatment focuses on centrally acting agents (SNRIs, gabapentinoids, low-dose naltrexone), exercise, CBT, and sleep optimization. Opioids are generally ineffective or harmful in this population.

<image>Venn diagram showing the three mechanistic pain categories -- nociceptive, neuropathic, and nociplastic -- with overlapping zones illustrating mixed pain states, annotated with clinical examples in each region: osteoarthritis in nociceptive, postherpetic neuralgia in neuropathic, fibromyalgia in nociplastic, chemotherapy-induced painful neuropathy with tissue inflammation in the nociceptive-neuropathic overlap, and chronic low back pain with central sensitization features in the nociceptive-nociplastic overlap</image>

ICD-11 Chronic Pain Classification

The WHO ICD-11, effective January 2022, introduced for the first time a systematic classification of chronic pain as a distinct entity rather than merely a symptom of something else.

Chronic Primary Pain

Chronic primary pain is defined as chronic pain in one or more anatomical regions that is associated with significant emotional distress or functional disability and cannot be better explained by another chronic pain condition. This category legitimizes conditions that were previously dismissed or coded under vague categories. Its subtypes include chronic widespread pain (fibromyalgia), chronic primary musculoskeletal pain, chronic primary headache, chronic primary visceral pain, and complex regional pain syndrome.

Chronic Secondary Pain Syndromes

Chronic secondary pain is pain secondary to an identifiable underlying disease. It includes six subcategories: chronic cancer-related pain (caused by cancer itself or its treatment), chronic postsurgical or post-traumatic pain (persisting more than three months after surgery or trauma, beyond expected healing), chronic neuropathic pain (peripheral and central subtypes), chronic secondary headache or orofacial pain (such as medication-overuse headache or temporomandibular disorders), chronic secondary visceral pain (such as chronic pancreatitis or endometriosis), and chronic secondary musculoskeletal pain (such as osteoarthritis, rheumatoid arthritis, or spondylosis).

Clinical Significance of ICD-11

The ICD-11 classification provides specific diagnostic codes for chronic pain, enabling epidemiological tracking, resource allocation, and research. It distinguishes chronic primary pain (pain as the disease) from chronic secondary pain (pain as a symptom), and it encourages biopsychosocial assessment by requiring documentation of functional and emotional impact.

<image>Hierarchical flowchart of the ICD-11 chronic pain classification system showing the top-level division into chronic primary pain and chronic secondary pain (with its six subtypes: cancer-related, postsurgical/post-traumatic, neuropathic, headache/orofacial, visceral, and musculoskeletal), with clinical examples branching from each category and color-coded by predominant pain mechanism (nociceptive, neuropathic, nociplastic)</image>

The Biopsychosocial Model

Origins

George Engel proposed the biopsychosocial model in 1977 as an alternative to the reductionist biomedical model, which assumed that all disease could be explained by measurable biological processes. Loeser's concentric model of pain illustrates the concept with four nested layers: nociception at the center, surrounded by pain, then suffering, and finally pain behavior at the outermost ring. Each layer adds a dimension that purely biological thinking cannot capture.

Biological Factors

Biological contributors to chronic pain include tissue pathology, peripheral and central sensitization, genetic predisposition (COMT, SCN9A, and OPRM1 polymorphisms), neuroinflammation, and comorbid medical conditions.

Psychological Factors

Pain catastrophizing -- comprising rumination, magnification, and helplessness -- is the strongest psychological predictor of poor outcomes and is measured by the Pain Catastrophizing Scale. Fear-avoidance beliefs (fear of movement or reinjury leading to deconditioning and disability) are assessed with the Fear-Avoidance Beliefs Questionnaire. Self-efficacy, the belief in one's ability to manage pain, is a protective factor. Depression, anxiety, PTSD, adverse childhood experiences (ACEs), and cognitive factors such as attention, expectation, and meaning attribution all contribute to the chronic pain experience.

Social Factors

Social contributors include socioeconomic status, employment status, disability compensation and litigation, social support networks, family dynamics, cultural beliefs about pain, healthcare system interactions (including iatrogenic factors and opioid prescribing patterns), access to multidisciplinary care, and health literacy and language barriers.

Clinical Application

Every chronic pain assessment should explicitly address all three domains, and treatment plans should target modifiable factors across all of them. The biopsychosocial model does not mean pain is "in the patient's head" -- it means pain emerges from the interaction of biological, psychological, and social factors, and effective treatment must address all three.

Mixed Pain States

Many chronic pain conditions involve multiple mechanisms simultaneously. Chronic low back pain can combine nociceptive elements (facet joints, discs) with neuropathic components (radiculopathy) and nociplastic features (central sensitization). Cancer pain often involves both nociceptive (tumor invasion) and neuropathic (nerve compression, chemotherapy) mechanisms. Osteoarthritis begins as purely nociceptive (synovitis, bone-on-bone contact) but in advanced disease develops nociplastic features through central sensitization. Recognizing these mixed pain states is essential because it guides multimodal, mechanism-based therapy rather than a one-size-fits-all approach.

Clinical Pearls

The 2020 IASP definition of pain explicitly states that pain and nociception are different phenomena -- a patient can have pain without nociception (as in central sensitization or nociplastic pain) and nociception without pain (as during general anesthesia or in congenital insensitivity to pain). Nociplastic pain is not a diagnosis of exclusion but a mechanistic descriptor that can coexist with nociceptive and neuropathic pain in the same patient; recognizing it changes treatment strategy away from peripherally targeted interventions and toward centrally acting agents and rehabilitation. The ICD-11 chronic primary pain category represents a paradigm shift: for the first time, conditions like fibromyalgia and CRPS have specific chronic pain codes rather than being shoehorned into musculoskeletal or psychiatric categories. A biopsychosocial formulation is not optional in chronic pain management -- failure to address psychological and social factors is as negligent as failure to identify a treatable structural pathology.

References

1. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27.
2. Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382-1386.
3. Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157(8):1599-1606.
4. Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28-37.

Read this lecture as Markdown